Rechallenging with anti-PD-1 therapy in advanced renal cell carcinoma

Lancet. 2024 Oct 5;404(10460):1280-1282. doi: 10.1016/S0140-6736(24)01866-X. Epub 2024 Sep 13.
No abstract available

MeSH terms

  • Carcinoma, Renal Cell* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors* / therapeutic use
  • Kidney Neoplasms* / drug therapy
  • Programmed Cell Death 1 Receptor* / antagonists & inhibitors

Substances

  • Immune Checkpoint Inhibitors
  • Programmed Cell Death 1 Receptor